State Street Corp Increases Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

State Street Corp boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 17.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 667,868 shares of the company’s stock after buying an additional 99,244 shares during the quarter. State Street Corp owned approximately 4.42% of U.S. Physical Therapy worth $56,522,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Stifel Financial Corp raised its holdings in shares of U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after purchasing an additional 6,154 shares during the last quarter. HighTower Advisors LLC increased its stake in U.S. Physical Therapy by 13.6% in the 3rd quarter. HighTower Advisors LLC now owns 4,714 shares of the company’s stock valued at $399,000 after buying an additional 566 shares during the last quarter. Centiva Capital LP lifted its position in shares of U.S. Physical Therapy by 42.4% during the 3rd quarter. Centiva Capital LP now owns 4,941 shares of the company’s stock worth $418,000 after buying an additional 1,470 shares in the last quarter. Benjamin Edwards Inc. boosted its stake in shares of U.S. Physical Therapy by 117.6% in the 3rd quarter. Benjamin Edwards Inc. now owns 5,885 shares of the company’s stock worth $498,000 after buying an additional 3,181 shares during the last quarter. Finally, Rockefeller Capital Management L.P. grew its holdings in shares of U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after acquiring an additional 25,393 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH opened at $92.43 on Thursday. The firm has a market capitalization of $1.40 billion, a PE ratio of 98.33, a P/E/G ratio of 4.23 and a beta of 1.46. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average price of $90.02 and a two-hundred day moving average price of $89.80. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.90%. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Insider Buying and Selling at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Nancy Ham sold 1,172 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,412 shares of company stock valued at $706,605 in the last 90 days. 1.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

USPH has been the topic of a number of recent analyst reports. Barrington Research reiterated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $100.00 to $115.00 in a report on Monday. JPMorgan Chase & Co. raised their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a research note on Monday. They issued an “outperform” rating and a $113.00 target price on the stock. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Buy” and a consensus target price of $114.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.